NDC 63187-173

Diazepam

Diazepam

Diazepam is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Proficient Rx Lp. The primary component is Diazepam.

Product ID63187-173_0471cce6-7ddc-4530-a794-3da0d7fd94d4
NDC63187-173
Product TypeHuman Prescription Drug
Proprietary NameDiazepam
Generic NameDiazepam
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date1986-12-10
Marketing CategoryANDA / ANDA
Application NumberANDA071321
Labeler NameProficient Rx LP
Substance NameDIAZEPAM
Active Ingredient Strength5 mg/1
Pharm ClassesBenzodiazepine [EPC], Benzodiazepines [CS]
DEA ScheduleCIV
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 63187-173-01

1 TABLET in 1 BOTTLE (63187-173-01)
Marketing Start Date2021-10-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 63187-173-90 [63187017390]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-10-01

NDC 63187-173-10 [63187017310]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-01

NDC 63187-173-02 [63187017302]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-01

NDC 63187-173-15 [63187017315]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2015-09-01

NDC 63187-173-60 [63187017360]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-10-01

NDC 63187-173-30 [63187017330]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2014-10-01

NDC 63187-173-21 [63187017321]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-02-01

NDC 63187-173-20 [63187017320]

Diazepam TABLET
Marketing CategoryANDA
Application NumberANDA071321
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-01

Drug Details

Active Ingredients

IngredientStrength
DIAZEPAM5 mg/1

OpenFDA Data

SPL SET ID:e7542d46-2586-4225-b07d-2633116bfa0a
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 197591
  • Pharmacological Class

    • Benzodiazepine [EPC]
    • Benzodiazepines [CS]

    NDC Crossover Matching brand name "Diazepam" or generic name "Diazepam"

    NDCBrand NameGeneric Name
    0054-3188DiazepamDiazepam
    0093-6137DiazepamDiazepam
    0093-6138DiazepamDiazepam
    0093-6139DiazepamDiazepam
    0121-0905DiazepamDiazepam
    0172-3925DiazepamDiazepam
    0172-3926DiazepamDiazepam
    0172-3927DiazepamDiazepam
    68071-4030DiazepamDiazepam
    68071-3330DiazepamDiazepam
    68071-3270DiazepamDiazepam
    68071-4181DiazepamDiazepam
    68071-4770DiazepamDiazepam
    68071-4829DiazepamDiazepam
    68094-750DiazepamDiazepam
    68682-652DiazepamDiazepam
    68682-650DiazepamDiazepam
    68682-655DiazepamDiazepam
    68788-6942DiazepamDiazepam
    68788-9207DiazepamDiazepam
    68788-6851DiazepamDiazepam
    68788-9937DiazepamDiazepam
    68788-9208DiazepamDiazepam
    68788-9936DiazepamDiazepam
    0527-1768DiazepamDiazepam
    0527-1767DiazepamDiazepam
    69339-136DiazepamDiazepam
    70518-0162DiazepamDiazepam
    70518-0014DiazepamDiazepam
    70518-1713DiazepamDiazepam
    70518-1270DiazepamDiazepam
    70518-1856DiazepamDiazepam
    0603-3215DiazepamDiazepam
    71335-0142DiazepamDiazepam
    71335-0444DiazepamDiazepam
    71335-0495DiazepamDiazepam
    71335-0616DiazepamDiazepam
    0615-7800DiazepamDiazepam
    0615-8049DiazepamDiazepam
    0904-5880DiazepamDiazepam
    10544-161DiazepamDiazepam
    11704-600DiazepamDiazepam
    12634-698DIAZEPAMDIAZEPAM
    12634-529DIAZEPAMDIAZEPAM
    17856-3188DiazepamDiazepam
    21695-265DiazepamDiazepam
    21695-264DiazepamDiazepam
    21695-889DiazepamDiazepam
    21695-263DiazepamDiazepam
    33261-034DiazepamDiazepam

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.